2004
DOI: 10.1128/aem.70.2.999-1007.2004
|View full text |Cite
|
Sign up to set email alerts
|

Coexpression of Genetically Engineered 3-Ketoacyl-ACP Synthase III ( fabH ) and Polyhydroxyalkanoate Synthase ( phaC ) Genes Leads to Short-Chain-Length-Medium-Chain-Length Polyhydroxyalkanoate Copolymer Production from Glucose in Escherichia coli JM109

Abstract: Polyhydroxyalkanoates (PHAs) can be divided into three main types based on the sizes of the monomers incorporated into the polymer. Short-chain-length (SCL) PHAs consist of monomer units of C 3 to C 5 , mediumchain-length (MCL) PHAs consist of monomer units of C 6 to C 14 , and SCL-MCL PHAs consist of monomers ranging in size from C 4 to C 14 . Although previous studies using recombinant Escherichia coli have shown that either SCL or MCL PHA polymers could be produced from glucose, this study presents the firs… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
48
0
2

Year Published

2005
2005
2020
2020

Publication Types

Select...
5
4

Relationship

1
8

Authors

Journals

citations
Cited by 67 publications
(51 citation statements)
references
References 35 publications
(41 reference statements)
1
48
0
2
Order By: Relevance
“…Limited bioavailability of PAHs and slow transformation to the metabolites in primary metabolism may be the cause of inhibition of PHA biosynthesis during phenanthrene degradation. It is noteworthy that de novo biosynthesis of fatty acid and PHAs shares common intermediates, ketoacyl-acyl-carrierproteins (Nomura et al 2004;Rehm et al 2001). Because of the possible competition between the two metabolic pathways, changes in fatty acid profiles may be interconnected with PHA contents.…”
Section: Discussionmentioning
confidence: 99%
“…Limited bioavailability of PAHs and slow transformation to the metabolites in primary metabolism may be the cause of inhibition of PHA biosynthesis during phenanthrene degradation. It is noteworthy that de novo biosynthesis of fatty acid and PHAs shares common intermediates, ketoacyl-acyl-carrierproteins (Nomura et al 2004;Rehm et al 2001). Because of the possible competition between the two metabolic pathways, changes in fatty acid profiles may be interconnected with PHA contents.…”
Section: Discussionmentioning
confidence: 99%
“…Copolymerization with various hydroxyalkanoate (HA) units is known to be effective in improving the physical properties and functionalities of PHA, and therefore, the syntheses of various copolymers have been attempted (Dai et al 2008;Fukui et al 1999;Han et al 2009;Hu et al 2011;Matsumoto et al 2011;Matsusaki et al 1998;Nomura et al 2004;Page et al 1992;Shozui et al 2009;Tajima et al 2009;Tajima et al 2012;Tanadchangsaeng et al 2009;Valentin et al 2000;Valentin, Reister and Gruys 2000). However, few studies have been carried out into the introduction of monomer units bearing amino and carboxyl groups, which exhibit high reactivity and are useful for PHA functionalization.…”
Section: Discussionmentioning
confidence: 99%
“…PHA synthases, which are key enzymes in PHA biosynthesis, catalyze the polymerization of (R)-hydroxyalkanoyl moieties in (R)-hydroxyalkanoyl coenzyme A (HACoA), with the concomitant release of CoA (Rehm 2003;Taguchi and Doi 2004). The…”
Section: Introductionmentioning
confidence: 99%
“…In our previous study, we demonstrated that coexpression of mutant 3-ketoacyl-acyl carrier protein (ACP) synthase III genes (fabH) with PHA synthase genes (phaC) leads to the production of SCL-MCL PHA in recombinant Escherichia coli grown in the presence of excess glucose (16). That study proposes that substrates for PHA production are derived from the fatty acid biosynthesis pathway (Fig.…”
mentioning
confidence: 99%